Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Blueprint Medicines Corp (NASDAQ: BPMC) closed at $95.30 down -4.76% from its previous closing price of $100.06. In other words, the price has decreased by -$4.76 from its previous closing price. On the day, 1.28 million shares were traded.
Ratios:
For a deeper understanding of Blueprint Medicines Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.75 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 2.08 whereas as Long-Term Debt/Eq ratio is at 1.72.
On March 17, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $135.Jefferies initiated its Buy rating on March 17, 2025, with a $135 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 27 ’25 when Albers Jeffrey W. bought 5,000 shares for $101.14 per share.
Rossi Christina sold 2,274 shares of BPMC for $228,557 on May 19 ’25. The CHIEF OPERATING OFFICER now owns 64,718 shares after completing the transaction at $100.51 per share. On May 05 ’25, another insider, Rossi Christina, who serves as the CHIEF OPERATING OFFICER of the company, sold 2,274 shares for $101.75 each. As a result, the insider received 231,386 and left with 66,992 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 10.95 while its Price-to-Book (P/B) ratio in mrq is 17.98.
Stock Price History:
Over the past 52 weeks, BPMC has reached a high of $121.90, while it has fallen to a 52-week low of $73.04. The 50-Day Moving Average of the stock is 4.11%, while the 200-Day Moving Average is calculated to be 2.06%.
Shares Statistics:
A total of 64.56M shares are outstanding, with a floating share count of 62.21M. Insiders hold about 3.68% of the company’s shares, while institutions hold 106.87% stake in the company.
